René Muttenzer

81 year

Health Technology

Consumer Services

Profile

Dr. René Muttenzer is on the Board of Directors at Polyphor AG and Molecular Health AG.
Dr. Muttenzer was previously employed as a Principal by Novartis AG.
He also served on the board at Acino Holding AG.
He received his graduate degree from the University of Basel.

Former positions of René Muttenzer

Companies	Position	End
ACINO HOLDING AG	Director/Board Member	2012-03-30
NOVARTIS AG	Corporate Officer/Principal	-
Posbelduf Biotech AG Posbelduf Biotech AG Pharmaceuticals: MajorHealth Technology Molecular Health AG provides clinico-molecular informatic solutions. The firm’s approach allows doctors translate patient-specific molecular and genomic data, clinical history, and published scientific evidence into drug choices. The company was founded by Friedrich von Bohlen in 2004 and is headquartered in Basel, Switzerland.	Director/Board Member	-
SPEXIS AG	Director/Board Member	-

See the detail of René Muttenzer's experience

Training of René Muttenzer

University of Basel

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of René Muttenzer's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
SPEXIS AG	Health Technology
NOVARTIS AG	Health Technology

Private companies	2
Acino International AG Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland.	Health Technology
Posbelduf Biotech AG Posbelduf Biotech AG Pharmaceuticals: MajorHealth Technology Molecular Health AG provides clinico-molecular informatic solutions. The firm’s approach allows doctors translate patient-specific molecular and genomic data, clinical history, and published scientific evidence into drug choices. The company was founded by Friedrich von Bohlen in 2004 and is headquartered in Basel, Switzerland.	Health Technology